Hirsch Andrew
Insider CIK 1586707 · BIND PRESIDENT & CEO, Director · AGIO Chief Financial Officer · EDIT Director · CCCC See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EDIT Editas Medicine, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 51,700 | — | $0 | 51,700 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2026-02-15 | 2026-02-18 | 20,400 | — | $0 | 1,083,991 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2026-02-15 | 2026-02-18 | 9,057 | $1.89 | $17.1K | 1,074,934 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2026-02-14 | 2026-02-18 | 81,725 | — | $0 | 1,123,145 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2026-02-14 | 2026-02-18 | 39,154 | $1.89 | $74.0K | 1,083,991 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2026-02-13 | 2026-02-18 | 700,000 | — | $0 | 1,123,145 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2025-06-06 | 2025-06-10 | 37,500 | — | $0 | 37,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2025-02-15 | 2025-02-18 | 9,370 | $3.18 | $29.8K | 423,145 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2025-02-14 | 2025-02-18 | 335,300 | — | $0 | 335,300 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2025-02-14 | 2025-02-18 | 12,847 | $3.18 | $40.9K | 432,515 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2025-02-14 | 2025-02-18 | 223,500 | — | $0 | 445,362 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2024-11-07 | 2024-11-12 | 12,500 | — | $0 | 35,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2024-11-07 | 2024-11-12 | 12,500 | — | $0 | 227,412 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2024-11-07 | 2024-11-12 | 5,550 | $6.04 | $33.5K | 221,862 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2024-09-16 | 2024-09-17 | 7,500 | — | $0 | 47,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2024-09-16 | 2024-09-17 | 7,500 | — | $0 | 218,241 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2024-09-16 | 2024-09-17 | 3,329 | $6.36 | $21.2K | 214,912 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2024-05-30 | 2024-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2024-02-15 | 2024-02-15 | 6,560 | $7.90 | $51.8K | 210,741 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-15 | 465,500 | — | $0 | 465,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2024-02-14 | 2024-02-15 | 103,400 | — | $0 | 217,301 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2023-09-18 | 2023-09-19 | 489,600 | — | $0 | 489,600 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2023-08-30 | 2023-08-31 | 7,500 | — | $0 | 55,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2023-08-30 | 2023-08-31 | 2,205 | $2.93 | $6.5K | 113,901 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2023-08-30 | 2023-08-31 | 7,500 | — | $0 | 116,106 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2023-02-15 | 2023-02-15 | 367,200 | — | $0 | 367,200 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award | 2023-02-15 | 2023-02-15 | 81,600 | — | $0 | 108,606 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2023-01-30 | 2023-02-01 | 12,500 | — | $0 | 62,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2023-01-30 | 2023-02-01 | 12,500 | — | $0 | 31,325 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2023-01-30 | 2023-02-01 | 4,319 | $7.78 | $33.6K | 27,006 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | F Tax w/h | 2022-05-26 | 2022-06-14 | 3,675 | $7.01 | $25.8K | 18,825 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise deriv | 2022-05-25 | 2022-05-27 | 12,500 | — | $0 | 75,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | M Exercise | 2022-05-25 | 2022-05-27 | 12,500 | — | $0 | 22,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | P Buy | 2022-04-12 | 2022-04-12 | 10,000 | $8.40 | $84.0K | 10,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2022-02-23 | 2022-02-23 | 87,500 | — | $0 | 87,500 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2021-06-03 | 2021-06-07 | 11,538 | — | $0 | 11,538 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2020-10-01 | 2020-10-05 | 1,691,672 | — | $0 | 1,691,672 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2020-06-10 | 2020-06-12 | 11,538 | — | $0 | 11,538 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-04-22 | 2020-04-24 | 5,893 | — | $0 | 11,785 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-04-22 | 2020-04-24 | 5,893 | — | $0 | 26,199 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | F Tax w/h | 2020-04-22 | 2020-04-24 | 1,927 | $45.91 | $88.5K | 24,272 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | F Tax w/h | 2020-04-14 | 2020-04-15 | 1,599 | $40.64 | $65.0K | 20,306 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-04-13 | 2020-04-15 | 5,387 | — | $0 | 10,775 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-04-13 | 2020-04-15 | 5,387 | — | $0 | 21,905 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | F Tax w/h | 2020-02-24 | 2020-02-25 | 1,056 | $48.66 | $51.4K | 16,518 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-02-22 | 2020-02-25 | 3,333 | — | $0 | 6,667 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-02-22 | 2020-02-25 | 3,333 | — | $0 | 17,574 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | F Tax w/h | 2020-02-18 | 2020-02-19 | 886 | $52.01 | $46.1K | 14,241 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-02-16 | 2020-02-19 | 2,750 | — | $0 | 2,750 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-02-16 | 2020-02-19 | 2,750 | — | $0 | 15,127 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-02-14 | 2020-02-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-02-14 | 2020-02-19 | 45,000 | — | $0 | 45,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 11,538 | — | $0 | 11,538 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-04-22 | 2019-04-24 | 17,678 | — | $0 | 17,678 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-02-22 | 2019-02-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-02-22 | 2019-02-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | F Tax w/h | 2019-02-19 | 2019-02-20 | 821 | $58.03 | $47.6K | 12,374 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-02-16 | 2019-02-20 | 2,750 | — | $0 | 5,500 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-02-16 | 2019-02-20 | 2,750 | — | $0 | 13,195 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | F Tax w/h | 2019-01-22 | 2019-01-23 | 4,555 | $52.82 | $240.6K | 10,445 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-01-20 | 2019-01-23 | 15,000 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-01-20 | 2019-01-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-07-20 | 2018-07-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2018-06-15 | 2018-06-19 | 11,538 | — | $0 | 11,538 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-02-16 | 2018-02-20 | 8,250 | — | $0 | 8,250 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-02-16 | 2018-02-20 | 33,000 | — | $0 | 33,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2017-05-30 | 2017-05-31 | 23,076 | — | $0 | 23,076 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2017-02-21 | 2017-02-23 | 47,600 | — | $0 | 47,600 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2016-09-20 | 2016-09-21 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2015-06-22 | 2015-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2015-03-07 | 2015-03-10 | 140,000 | — | $0 | 140,000 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2014-03-11 | 2014-03-13 | 45,000 | — | $0 | 45,000 | SEC↗ |